Squamous Cell Carcinoma

From Canonica AI

Overview

Squamous Cell Carcinoma (SCC) is a type of skin cancer that originates in the squamous cells, which are flat cells located in the outer part of the epidermis. SCC is the second most common form of skin cancer, following basal cell carcinoma. It is known for its potential to metastasize and spread to other parts of the body, making early detection and treatment crucial.

Pathophysiology

Squamous cells are found in various tissues throughout the body, including the skin, lungs, and mucous membranes. SCC arises when these cells undergo malignant transformation due to genetic mutations often induced by factors such as ultraviolet (UV) radiation, chemical exposure, or chronic inflammation. The mutations lead to uncontrolled cellular proliferation and the formation of a tumor.

Genetic Mutations

The most common genetic mutations involved in SCC include alterations in the TP53 gene, which encodes the tumor suppressor protein p53, and the CDKN2A gene, which encodes the p16 protein. These mutations disrupt normal cell cycle regulation, allowing for unchecked cell division and tumor growth.

Risk Factors

Several risk factors contribute to the development of SCC:

  • **UV Radiation**: Prolonged exposure to UV radiation from the sun or tanning beds is the primary risk factor.
  • **Chemical Exposure**: Contact with carcinogenic chemicals, such as arsenic, can increase the risk.
  • **Chronic Inflammation**: Conditions that cause long-term inflammation, such as chronic wounds or burns, can predispose individuals to SCC.
  • **Immunosuppression**: Patients with weakened immune systems, such as those on immunosuppressive therapy or with HIV/AIDS, are at higher risk.
  • **Genetic Predisposition**: Certain genetic conditions, such as xeroderma pigmentosum, increase susceptibility to SCC.

Clinical Presentation

SCC typically presents as a persistent, non-healing lesion on sun-exposed areas of the skin, such as the face, ears, neck, and hands. The lesion may appear as a scaly red patch, an open sore, a wart-like growth, or a raised bump with a central depression. Symptoms can include itching, tenderness, or bleeding.

Diagnosis

The diagnosis of SCC involves a combination of clinical examination and histopathological analysis. A dermatologist will perform a skin biopsy, removing a small sample of the suspicious lesion for microscopic examination. Histopathology will reveal atypical squamous cells with features such as keratinization, intercellular bridges, and nuclear atypia.

Staging

Staging of SCC is based on the TNM classification system, which considers the size and extent of the primary tumor (T), involvement of regional lymph nodes (N), and presence of distant metastasis (M). Staging helps guide treatment decisions and prognostication.

Treatment

Treatment options for SCC depend on the stage and location of the tumor, as well as the patient's overall health.

Surgical Options

  • **Excisional Surgery**: The tumor is surgically removed along with a margin of healthy tissue.
  • **Mohs Micrographic Surgery**: A specialized technique where the tumor is removed layer by layer, with each layer examined microscopically until no cancerous cells remain.
  • **Curettage and Electrodessication**: The tumor is scraped away, and the area is treated with electric current to destroy remaining cancer cells.

Non-Surgical Options

  • **Radiation Therapy**: High-energy radiation is used to target and destroy cancer cells, often used for tumors in difficult-to-treat locations.
  • **Topical Treatments**: Medications such as 5-fluorouracil or imiquimod can be applied directly to the skin to treat superficial SCC.
  • **Systemic Therapy**: Advanced cases may require chemotherapy or targeted therapy with agents such as EGFR inhibitors.

Prognosis

The prognosis for SCC is generally favorable when detected and treated early. The 5-year survival rate for localized SCC is high, but it decreases significantly if the cancer has metastasized. Regular follow-up and skin examinations are essential for early detection of recurrences or new lesions.

Prevention

Preventive measures include:

  • **Sun Protection**: Using sunscreen, wearing protective clothing, and avoiding peak sun hours.
  • **Regular Skin Checks**: Self-examinations and routine dermatological check-ups.
  • **Avoiding Tanning Beds**: Refraining from the use of artificial tanning devices.
  • **Managing Chronic Conditions**: Proper care of chronic wounds and inflammatory conditions.

See Also

References